Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marcos Lepe, M.D.

Concepts (102)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Marcos Lepe's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Marcos Lepe has written about over time.
Carcinoma, Ductal, Breast, 1 publications between 2017 and 2017, average publication date January 2017. Catenins, 1 publications between 2017 and 2017, average publication date January 2017. Cervix Uteri, 1 publications between 2018 and 2018, average publication date July 2018. Lymph Nodes, 2 publications between 2019 and 2020, average publication date November 2019. Biomedical Research, 1 publications between 2020 and 2020, average publication date June 2020. Research Design, 1 publications between 2020 and 2020, average publication date June 2020. Curriculum, 1 publications between 2020 and 2020, average publication date July 2020. Thyroid Nodule, 2 publications between 2020 and 2020, average publication date August 2020. Uterine Cervical Neoplasms, 2 publications between 2018 and 2023, average publication date January 2021. Biopsy, Fine-Needle, 5 publications between 2019 and 2024, average publication date October 2021. Cytodiagnosis, 2 publications between 2020 and 2023, average publication date March 2022. Cytological Techniques, 2 publications between 2020 and 2023, average publication date March 2022. Cell Transdifferentiation, 1 publications between 2024 and 2024, average publication date June 2024.

To see the data from this visualization as text, click here.
Lepe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (102)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.